All too easy: Obama signs US FDA user fee bill without fanfare
This article was originally published in Scrip
Perhaps it was a move by the White House to avoid any uncomfortable photos of President Barack Obama surrounded by drug industry insiders after the rumpus raised in recent weeks over email exchanges during the 2009 health care reform negotiations, but the legislation reauthorizing the Prescription Drug User Fee Act (PDUFA) quietly slid across the president’s desk on 9 July, with no fanfare (scripintelligence, 11 June 2012, 1 June 2012).
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.